Home Featured Page 209

Featured

Latest

Josh Lipson, PhD & Roman Palitsky, MDiv, PhD: Psychedelic Harms and the Post-Psychedelic Challenges Study

Why Perimenopause Belongs in Psychedelic Research

The Psychedelic Practitioner Issue 6: Preparedness (People)

Two Years After Rejection, Resilient Quietly Refiles MDMA for PTSD Application

Smooth Sailing: Definium’s LSD Voyage Hits Primary and Key Secondary Endpoints in GAD

PT286 – Joe Tafur, MD – Vital Psychedelic Conversations

Psychedelic Company Highlights in 2021

Psychedelic Science Leader Eleusis to Become Public Company in Merger with...

Awakn Life Sciences Signs MOU with Maps

Numinus Announces Key Milestones in MAPS-Sponsored MDMA-Assisted Therapy for PTSD Clinical...

Two thirds of physicians surveyed believe psilocybin therapy has potential benefit...

Psygen Receives Dealer’s Licence from Health Canada

Red Light Holland to Collaborate with Advocacy Group, Psychedelic Medicine Alliance...

Optimi Health Submits Natural Psilocybin Combined Drug Delivery and Extraction Formulations...

Entheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Psychedelics Today

EDITOR PICKS

Josh Lipson, PhD & Roman Palitsky, MDiv, PhD: Psychedelic Harms and...

Why Perimenopause Belongs in Psychedelic Research

The Psychedelic Practitioner Issue 6: Preparedness (People)

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Josh Lipson, PhD & Roman Palitsky, MDiv, PhD: Psychedelic Harms and the Post-Psychedelic Challenges Study

Why Perimenopause Belongs in Psychedelic Research

The Psychedelic Practitioner Issue 6: Preparedness (People)

Two Years After Rejection, Resilient Quietly Refiles MDMA for PTSD Application

Smooth Sailing: Definium’s LSD Voyage Hits Primary and Key Secondary Endpoints in GAD

PT286 – Joe Tafur, MD – Vital Psychedelic Conversations

Psychedelic Company Highlights in 2021

Psychedelic Science Leader Eleusis to Become Public Company in Merger with...

Awakn Life Sciences Signs MOU with Maps

Numinus Announces Key Milestones in MAPS-Sponsored MDMA-Assisted Therapy for PTSD Clinical...

Two thirds of physicians surveyed believe psilocybin therapy has potential benefit...

Psygen Receives Dealer’s Licence from Health Canada

Red Light Holland to Collaborate with Advocacy Group, Psychedelic Medicine Alliance...

Optimi Health Submits Natural Psilocybin Combined Drug Delivery and Extraction Formulations...

Entheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Psychedelics Today

EDITOR PICKS

Josh Lipson, PhD & Roman Palitsky, MDiv, PhD: Psychedelic Harms and...

Why Perimenopause Belongs in Psychedelic Research

The Psychedelic Practitioner Issue 6: Preparedness (People)

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY